Skip to content

MaayanLab/creeds

Repository files navigation

CREEDS: CRowd Extracted Expression of Differential Signatures

The web portal for serving the crowdsourced gene expression signatures from Gene Expression Omnibus: http://amp.pharm.mssm.edu/creeds/. The web portal allows users to query, download, and visualize these gene expression signatures.

Abstract

Gene expression data are accumulating exponentially in public repositories. Reanalysis and integration of themed collections from these studies may provide new insights, but requires further human curation. Here we report a crowdsourcing project to annotate and reanalyse a large number of gene expression profiles from Gene Expression Omnibus (GEO). Through a massive open online course on Coursera, over 70 participants from over 25 countries identify and annotate 2,460 single-gene perturbation signatures, 839 disease versus normal signatures, and 906 drug perturbation signatures. All these signatures are unique and are manually validated for quality. Global analysis of these signatures confirms known associations and identifies novel associations between genes, diseases and drugs. The manually curated signatures are used as a training set to develop classifiers for extracting similar signatures from the entire GEO repository. We develop a web portal to serve these signatures for query, download and visualization.

Publication

Wang, Z., Monteiro, C. D., Jagodnik, K. M., Fernandez, N. F., Gundersen, G. W., ... & Ma'ayan, A. (2016) Extraction and Analysis of Signatures from the Gene Expression Omnibus by the Crowd.
Nature Communications doi: 10.1038/ncomms12846 PMID: 27667448

API Documentation

Three API endpoints have been implemented searching, querying, and retrieving associated metadata for gene expression signatures. For more details, visit http://amp.pharm.mssm.edu/CREEDS/#help/#api-doc. Tutorials walking through all the API endpoints with examples are also available in Python and R.

The site can also be accessed through http://amp.pharm.mssm.edu/creeds2/.

In the News